Combining smoking information and molecular markers improves prognostication in patients with urothelial carcinoma of the bladder

Urologic Oncology: Seminars and Original Investigations

Volumn 32, Issue 4, 2014, Pages 433-440

  Wang, Lily C ^a   Xylinas, Evanguelos ^a,b   Kent, Matthew T ^c   Kluth, Luis A ^a,d   Rink, Michael ^a,d   Jamzadeh, Asha ^a   Rieken, Malte ^a   Al Awamlh, Bashir Al Hussein ^a   Trinh, Quoc Dien ^e   Sun, Maxine ^e   Karakiewicz, Pierre I ^e   Novara, Giacomo ^f   Chrystal, James ^a   Zerbib, Marc ^b   Scherr, Douglas S ^a   Lotan, Yair ^g   Vickers, Andrew ^c   Shariat, Shahrokh F ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b Institut Cochin   (France)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^e UNIVERSITÉ DE MONTRÉAL   (Canada)

^f UNIVERSITY OF PADOVA   (Italy)

^g UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Biomarkers; Prognostic; Radical cystectomy; Smoking; Survival; Urothelial carcinoma of the bladder

Indexed keywords

KI 67 ANTIGEN; PROTEIN P21; PROTEIN P27; PROTEIN P53; RETINOBLASTOMA PROTEIN; SURVIVIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURGERY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTECTOMY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PELVIS LYMPH NODE; PRIORITY JOURNAL; SMOKING; TISSUE MICROARRAY; TRANSITIONAL CELL CARCINOMA; UROTHELIAL CARCINOMA OF THE BLADDER; BLADDER TUMOR; CANCER GRADING; CANCER STAGING; COHORT ANALYSIS; ENZYME IMMUNOASSAY; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; SURVIVAL RATE; TUMOR RECURRENCE;

AGED; BIOMARKERS, TUMOR; COHORT STUDIES; CYSTECTOMY; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; SMOKING; SURVIVAL RATE; URINARY BLADDER NEOPLASMS;

EID: 84899472096     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2013.10.015     Document Type: Article

References (26)

1. Stein J.P., Lieskovsky G., Cote R., Groshen S., Feng A.C., Boyd S., et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 2001, 19:666-675.
2. Shariat S.F., Karakiewicz P.I., Palapattu G.S., Lotan Y., Rogers C.G., Amiel G.E., et al. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. J Urol 2006, 176:2414-2422. [discussion 2422].
3. Stenzl A., Cowan N.C., De Santis M., Kuczyk M.A., Merseburger A.S., Ribal M.J., et al. Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines. Eur Urol 2011, 59:1009-1018.
4. Hautmann R.E., de Petriconi R.C., Pfeiffer C., Volkmer B.G. Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy: long-term results in 1100 patients. Eur Urol 2012, 61:1039-1047.
5. Shariat S.F., Chade D.C., Karakiewicz P.I., Ashfaq R., Isbarn H., Fradet Y., et al. Combination of multiple molecular markers can improve prognostication in patients with locally advanced and lymph node positive bladder cancer. J Urol 2010, 183:68-75.
6. Shariat S.F., Karakiewicz P.I., Godoy G., Karam J.A., Ashfaq R., Fradet Y., et al. Survivin as a prognostic marker for urothelial carcinoma of the bladder: a multicenter external validation study. Clin Cancer Res 2009, 15:7012-7019.
7. Shariat S.F., Chromecki T.F., Cha E.K., Karakiewicz P.I., Sun M., Fradet Y., et al. Risk stratification of organ confined bladder cancer after radical cystectomy using cell cycle related biomarkers. J Urol 2012, 187:457-462.
8. Margulis V., Lotan Y., Karakiewicz P.I., Fradet Y., Ashfaq R., Capitanio U., et al. Multi-institutional validation of the predictive value of Ki-67 labeling index in patients with urinary bladder cancer. J Natl Cancer Inst 2009, 101:114-119.
9. Rink M., Xylinas E., Babjuk M., Pycha A., Karakiewicz P.I., Novara G., et al. Smoking reduces the efficacy of intravesical bacillus Calmette-Guerin immunotherapy in non-muscle-invasive bladder cancer. Eur Urol 2012, 62:1204-1206.
10. Rink M., Furberg H., Zabor E.C., Xylinas E., Babjuk M., Pycha A., et al. Impact of smoking and smoking cessation on oncologic outcomes in primary non-muscle-invasive bladder cancer. Eur Urol 2012, 63:724-732.
11. Burger M., Catto J.W., Dalbagni G., Grossman H.B., Herr H., Karakiewicz P., et al. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol 2013, 63:234-241.
12. Greene FL: AJCC cancer staging manual 6th ed. Greene Frederick L. et al. editors. New York; London: Springer; 2002.
13. Epstein J.I., Amin M.B., Reuter V.R., Mostofi F.K. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 1998, 22:1435-1448.
14. Fajkovic H., Cha E.K., Jeldres C., Robinson B.D., Rink M., Xylinas E., et al. Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis. Eur Urol 2012, 64:837-845.
15. Shariat S.F., Svatek R.S., Tilki D., Skinner E., Karakiewicz P.I., Capitanio U., et al. International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy. BJU Int 2010, 105:1402-1412.
16. Novara G., Svatek R.S., Karakiewicz P.I., Skinner E., Ficarra V., Fradet Y., et al. Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4,400 patients. J Urol 2010, 183:2165-2170.
17. Benedict W.F., Lerner S.P., Zhou J., Shen X., Tokunaga H., Czerniak B. Level of retinoblastoma protein expression correlates with p16 (MTS-1/INK4A/CDKN2) status in bladder cancer. Oncogene 1999, 18:1197-1203.
18. Shariat S.F., Tokunaga H., Zhou J., Kim J., Ayala G.E., Benedict W.F., et al. p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer. J Clin Oncol 2004, 22:1014-1024.
19. Shariat S.F., Ashfaq R., Sagalowsky A.I., Lotan Y. Correlation of cyclin D1 and E1 expression with bladder cancer presence, invasion, progression, and metastasis. Hum Pathol 2006, 37:1568-1576.
20. Margulis V., Shariat S.F., Ashfaq R., Sagalowsky A.I., Lotan Y. Ki-67 is an independent predictor of bladder cancer outcome in patients treated with radical cystectomy for organ-confined disease. Clin Cancer Res 2006, 12:7369-7373.
21. Shariat S.F., Zlotta A.R., Ashfaq R., Sagalowsky A.I., Lotan Y. Cooperative effect of cell-cycle regulators expression on bladder cancer development and biologic aggressiveness. Mod Pathol 2007, 20:445-459.
22. Rink M., Xylinas E., Babjuk M., Hansen J., Pycha A., Comploj E., et al. Impact of smoking on outcomes of patients with a history of recurrent nonmuscle invasive bladder cancer. J Urol 2012, 188:2120-2128.
23. Rink M., Xylinas E., Babjuk M., Pycha A., Karakiewicz P.I., Novara G., et al. Smoking reduces the efficacy of intravesical Bacillus Calmette-Guerin immunotherapy in non-muscle-invasive bladder cancer. Eur Urol 2012, 62:1204-1206.
24. Rink M., Xylinas E., Margulis V., Cha E.K., Ehdaie B., Raman J.D., et al. Impact of smoking on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy. Eur Urol 2012, 63:1082-1090.
25. Rink M., Zabor E.C., Furberg H., Xylinas E., Ehdaie B., Novara G., et al. Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomy. Eur Urol 2012, 64:456-464.
26. Rink M., Fajkovic H., Cha E.K., Gupta A., Karakiewicz P.I., Chun F.K., et al. Death certificates are valid for the determination of cause of death in patients with upper and lower tract urothelial carcinoma. Eur Urol 2012, 61:854-855.